Scattering of MCF7 cells by heregulin ß-1 depends on the MEK and p38 MAP kinase pathway

PLoS One. 2013;8(1):e53298. doi: 10.1371/journal.pone.0053298. Epub 2013 Jan 7.

Abstract

Heregulin (HRG) β1 signaling promotes scattering of MCF7 cells by inducing breakdown of adherens and tight junctions. Here, we show that stimulation with HRG-β1 causes the F-actin backbone of junctions to destabilize prior to the loss of adherent proteins and scattering of the cells. The adherent proteins dissociate and translocate from cell-cell junctions to the cytosol. Moreover, using inhibitors we show that the MEK1 pathway is required for the disappearance of F-actin from junctions and p38 MAP kinase activity is essential for scattering of the cells. Upon treatment with a p38 MAP kinase inhibitor, adherens junction complexes immediately reassemble, most likely in the cytoplasm, and move to the plasma membrane in cells dissociated by HRG-β1 stimulation. Subsequently, tight junction complexes form, most likely in the cytoplasm, and move to the plasma membrane. Thus, the p38 MAP kinase inhibitor causes a re-aggregation of scattered cells, even in the presence of HRG-β1. These results suggest that p38 MAP kinase signaling to adherens junction proteins regulates cell aggregation, providing a novel understanding of the regulation of cell-cell adhesion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Adherens Junctions / metabolism
  • Breast Neoplasms / metabolism
  • Cell Adhesion* / drug effects
  • Female
  • Humans
  • MAP Kinase Signaling System* / drug effects
  • MCF-7 Cells / cytology*
  • MCF-7 Cells / drug effects
  • MCF-7 Cells / metabolism
  • Neoplasms / metabolism
  • Neuregulin-1 / metabolism*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Actins
  • Neuregulin-1
  • heregulin beta1
  • p38 Mitogen-Activated Protein Kinases

Grants and funding

This work was supported by grants-in-aid from Japan’s Ministry of Education, Culture, Sports, Science and Technology, #20013044; a grant from the National Institute of Biomedical Innovation, Japan; and a grant from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.